|
Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection |
Logge C, Vettorazzi E, Fischer L, Nashan B, Sterneck M |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Logge C, Vettorazzi E, Fischer L, Nashan B, Sterneck M. Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection. Transplant International 2013; 26(5): 527-534 Indexing Status Subject indexing assigned by NLM MeSH Antiviral Agents /economics /therapeutic use; Cost-Benefit Analysis; Decision Support Techniques; Genotype; Hepacivirus /genetics; Hepatitis C, Chronic /drug therapy /economics /surgery; Humans; Interferon-alpha /economics /therapeutic use; Liver Transplantation /economics; Quality-Adjusted Life Years; Recurrence; Ribavirin /economics /therapeutic use; Treatment Outcome AccessionNumber 22013019837 Date bibliographic record published 30/05/2013 |
|
|
|